CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells

CIGB-300 is a clinical-grade anti-Protein Kinase CK2 peptide, binding both its substrate’s phospho-acceptor site and the CK2α catalytic subunit. The cyclic p15 inhibitory domain of CIGB-300 was initially selected in a phage display library screen for its ability to bind the CK2 phospho-acceptor doma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramón, Ailyn C., Basukala, Om, Massimi, Paola, Thomas, Miranda, Perera, Yasser, Banks, Lawrence., Perea, Silvio E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414295/
https://www.ncbi.nlm.nih.gov/pubmed/36016303
http://dx.doi.org/10.3390/v14081681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414295/
https://www.ncbi.nlm.nih.gov/pubmed/36016303
http://dx.doi.org/10.3390/v14081681

Ejemplares similares